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Abstract
Diabetic retinopathy is a leading cause of reduced visual acuity and acquired blindness. Available treatments are not
completely effective. We analyzed the effect of environmental enrichment on retinal damage induced by experimental
diabetes in adult Wistar rats. Diabetes was induced by an intraperitoneal injection of streptozotocin. Three days after vehicle
or streptozotocin injection, animals were housed in enriched environment or remained in a standard environment. Retinal
function (electroretinogram, and oscillatory potentials), retinal morphology, blood-retinal barrier integrity, synaptophysin,
astrocyte and Mu¨ller cell glial fibrillary acidic protein, vascular endothelial growth factor, tumor necrosis factor-a, and brain-
derived neurotrophic factor levels, as well as lipid peroxidation were assessed in retina from diabetic animals housed in
standard or enriched environment. Environmental enrichment preserved scotopic electroretinogram a-wave, b-wave and
oscillatory potential amplitude, avoided albumin-Evan’s blue leakage, prevented the decrease in retinal synaptophysin and
astrocyte glial fibrillary acidic protein levels, the increase in Mu¨ller cell glial fibrillary acidic protein, vascular endothelial
growth factor and tumor necrosis factor-a levels, as well as oxidative stress induced by diabetes. In addition, enriched
environment prevented the decrease in retinal brain-derived neurotrophic factor levels induced by experimental diabetes.
When environmental enrichment started 7 weeks after diabetes onset, retinal function was significantly preserved. These
results indicate that enriched environment could attenuate the early diabetic damage in the retina from adult rats.
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Introduction
Diabetic retinopathy (DR), a leading cause of reduced visual
acuity and acquired blindness, is a retinal hyperglycemia-related
ischemic disorder characterized by microvascular and neuroglial
alterations [1]. Nearly all individuals with type 1 diabetes, and
more than 60% of individuals with type 2 diabetes mellitus have
some degree of retinopathy after 20 years [2]. Current population-
based studies suggest that about one-third of the diabetic
population have signs of DR, and approximately one tenth have
vision-threatening stages of retinopathy [3,4].
Like other diabetic complications, the exact mechanism
underlying DR is still not completely understood. However, it is
well recognized that DR is a disorder that leads to increased
vascular permeability, neovascularization, edema, and lesions in
the retina (reviewed in [5]). At present, the treatments for
advanced stages of DR are laser photocoagulation, vitrectomy,
and intraocular administration of anti- vascular endothelial growth
factor (VEGF) agents, and corticosteroids. Although these
treatments have had considerable success rates, they are not
useful for early stages of DR, and do not completely eliminate the
risk of blindness (reviewed in [6]). Thus, new treatment strategies
that are preventive and/or can provide interventions in diabetes to
delay or prevent the progression of the retinal disease are needed.
The streptozotocin (STZ)-induced diabetes model in rat shows
many of the retinal alterations associated with human DR [7,8];
therefore, this model could be a useful tool for developing new
therapeutic strategies for DR.
Environmental conditions have been shown to rescue the
diabetic brain from neurodegenerative progression [9], and to
prevent or delay the development of memory deficits caused by
diabetes in adult rats [10]. In an enriched environment (EE),
animals are allowed the freedom to move and exercise voluntarily
in larger cages, with accessibility to complex stimuli (e.g. toys,
running wheels, etc.), thus being provided with more sensorial,
social, physical, and intellectual stimulation than animals housed
in standard (laboratory) conditions. Compelling evidence exists for
the influence of EE housing on enhanced neuronal growth, and
recovery following central nervous system injuries [11–13]. Landi
et al. [14] have shown that EE housing accelerates the maturation
of rat retinal acuity and an enhanced visual acuity was
demonstrated in mice exposed to EE from birth, which suggests
that the complexity of the visual environment greatly influences
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the visual system performance [15]. Furthermore, remarkable
therapeutic effects on the visual system after prolonged exposure to
EE from birth of rd10 mice, a mutant strain undergoing
progressive photoreceptor degeneration mimicking human retinitis
pigmentosa, were recently demonstrated [16]. Although the adult
retina has long been considered less plastic than the brain cortex
or hippocampus (the main loci of experience-dependent plasticity),
a marked upregulation of the nerve growth factor induced gene-A
and the activity-regulated cytoskeletal protein, two candidate-
plasticity genes, was described in adult rats that had been exposed
to an EE for 3 weeks [17]. Moreover, we have recently
demonstrated that EE housing after retinal ischemia significantly
protects retinal function and histology from ischemia/reperfusion
injury in adult rats [18], and a recent study has confirmed that the
outcome of retinal ischemia is improved by enriched housing in
adult rats [19], supporting that environmental stimuli can
significantly modify the extent of retinal damage in adult rats. In
this context, the aim of this work was to analyze the effect of EE




All animal procedures were in strict accordance with the ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research. The ethic committee of the School of Medicine,
University of Buenos Aires (Institutional Committee for the Care
and Use of Laboratory Animals, (CICUAL)) approved this study,
and all efforts were made to minimize animal suffering.
Animals
Adult male Wistar rats (average weight, 300650 g) were housed
in a standard animal room with food and water ad libitum, under
controlled conditions of humidity and temperature (2162uC). The
room was lighted by fluorescent lights (200 lux) that were turned
on and off automatically every 12 hours (on from 8.00 AM to 8.00
PM). Animals from the control group (standard environment, (SE))
were housed in standard laboratory cages (33.5645621.5 cm)
with two animals per cage. For EE housing, six animals at a time
were housed in big metallic cages (46.5678695 cm), containing
four floors and several food hoppers, water bottles, running
wheels, tubes, ramps and differently shaped objects (balls, ropes,
stones) repositioned once a day and fully substituted once a week.
Particular care was taken not to repeat cage arrangement and
object availability during the experiments, as previously described
[18]. Animals were caged in EE at 3 days after STZ injection.
Although food and water were offered ad libitum, location of the
hoppers and bottles was changed daily in order to stimulate
exploratory conduct. Cages were cleaned twice a week at the same
time and by the same protocol to that used for standard cage
cleaning [18]. For diabetes induction, a single intraperitoneal
injection of streptozotocin (STZ, 60 mg/kg in 0.1 M citrate buffer,
pH 4.5) was performed, whereas control rats received an equal
volume of citrate buffer. Animals were examined 3 days after
injections with a glucose meter (Bayer, Buenos Aires, Argentina),
and those with glycaemia greater than 350 mg/dl were considered
diabetic. Rats were weekly monitored and the weight and plasma
glucose levels were determined. In another set of experiments,
diabetic rats were housed in EE at 7 weeks of diabetes. The
housing conditions for experimental groups, and protocols for
retinal functional, histological and biochemical studies are shown
in Figure 1. A total number of 185 animals were used for the
experiments, distributed as follows: for ERG assessment during 10
weeks of diabetes: 22 control (10 in SE and 12 in EE) and 22
diabetic animals (10 in SE and 12 in EE). Five animals from each
group were used for histological analysis and 5 animals were used
for VEGF levels at 10 weeks of diabetes. For GFAP and Evan’s
Blue analysis: 13 animals/group were used. In addition, 20
animals were used to asses VEGF levels at 6 weeks of diabetes (5
SE-housed control or diabetic animals and 5 EE-housed control or
diabetic animals. For lipid peroxidation assessment, 20 animals
were used (5 control animals in SE or EE, and 5 diabetic animals
in SE or EE). For immunohistochemical studies, 20 animals were
used (5 control animals in SE or EE, and 5 diabetic animals in SE
or EE). Finally, 32 animals were used to evaluate the effect of EE
on the ERG from 7 to 10 weeks of diabetes (10 control animals in
SE, 10 diabetic animals that remained in SE the whole
experiment, and 12 animals that were changed from SE to EE
at 7 weeks of diabetes).
Cataract prevalence
Cataract (lens opalescence) development was weekly monitored
using a handheld ophthalmoscope equipped with a slit lamp.
Electroretinography
Electroretinograms (ERG) were recorded before and weekly
after diabetes induction, as previously described [18,20]. Briefly,
rats were dark-adapted for 6 h, and anesthetized with ketamine
hydrochloride (150 mg/kg) and xylazine hydrochloride (2 mg/kg)
administered intraperitoneally, under dim red illumination. Pupils
were dilated by topical application of phenylephrine hydrochloride
and tropicamide, and the cornea was intermittently irrigated with
balanced salt solution to prevent dehydration and allow electrical
contact with the recording electrode. Rats were placed facing the
stimulus at a distance of 20 cm. Recordings were completed within
20 min and animals were kept warm during and after the
procedure. A reference electrode was placed through the ear, a
grounding electrode was attached to the tail, and a gold electrode
was placed in contact with the central cornea. A 15W red light was
used to enable accurate electrode placement. This maneuver did
not significantly affect dark adaptation and was switched off during
the electrophysiological recordings. Scotopic ERGs were recorded
from both eyes simultaneously and 10 responses to flashes of
unattenuated white light (5 ms, 0.2 Hz) from a full-field/Ganzfeld
stimulator (light-emitting diodes) set at maximum brightness (9 cd
s/m2 without filter) were amplified, filtered (1.5-Hz low-pass filter,
1000 high-pass filter, notch activated) and averaged (Akonic BIO-
PC, Buenos Aires, Argentina). The a-wave amplitude was
measured as the difference in amplitude between the recording
at onset and the trough of the negative deflection, and the b-wave
amplitude was measured from the a-wave trough to the peak of the
b-wave. Latency was measured from stimulus onset to the a-wave
trough and b-wave peak. Runs were repeated 3 times with 5 min-
intervals to confirm consistency. Mean peak latencies and peak-to-
peak amplitudes of the responses from each group of rats were
compared. Oscillatory potentials (OPs) were assessed as previously
described [20]. Briefly, the same photic stimulator with a 0.2 Hz
frequency and filters of high (300 Hz) or low (100 Hz) frequency
were used. The amplitudes of the OPs were estimated by
measuring the heights from the baseline drawn between the
troughs of successive wavelets to their peaks. The sum of three OPs
was used for statistical analysis.
Histological Evaluation
Rats were anesthetized and intracardially perfused with saline
solution, followed by a fixative solution containing 4% formalde-
hyde in 0.1 M PBS, pH 7.4. Then, the eyeballs were carefully
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Figure 1. Housing conditions, and protocols for retinal functional, histological and biochemical studies. Three days after vehicle or STZ
injection, adult Wistar rats were housed in a standard laboratory cage (panel A) or EE cages (panel B). Panel C: Experimental groups and protocols for
functional, histological and biochemical studies. ERG was weekly recorded until week 10. Vascular permeability, GFAP immunostaining, retinal TNFa
and TBARS levels were analyzed in SE- or EE-housed animals that had been diabetic for 6 weeks. VEGF levels were analyzed by Western blot and
immunohistochemistry at 6 or 10 weeks of diabetes. Panel D: Diabetic animals housed in SE until week 7 were switched to EE, and ERG was weekly
recorded until week 10.
doi:10.1371/journal.pone.0101829.g001
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removed and immersed for 24 hours in the same fixative. After
dehydration, eyes were embedded in paraffin wax and sectioned
(5 mm) along the vertical meridian through the optic nerve head.
Microscopic images were digitally captured with a microscope
(Eclipse E400, Nikon, Tokyo, Japan); 6-V halogen lamp, 20 W,
equipped with a stabilized light source) and a camera (Coolpix s10;
Nikon; Abingdon, VA, USA). Sections were stained with
hematoxylin and eosin and were analyzed by masked observers.
The average thickness (in mm) of the total retina was measured for
each eye. Measurements were obtained at 1 mm dorsal and
ventral from the optic disc, as previously described [18,20]. For
each eye, results obtained from four separate sections were
averaged, and the mean of 5 eyes was recorded as the
representative value for each group.
Immunohistochemical studies
Antigen retrieval was performed by heating (90uC) slices for
30 minutes in citrate buffer (pH 6.3) and then preincubated with
2% normal horse serum, 0.1% BSA, and 0.4% Triton X-100 in
0.01 M PBS for 1 h. For specific immunodetection of retinal
ganglion cells (RGC), paraffin sections were incubated overnight
at 4uC with a goat policlonal anti-Brn3a antibody (1:500; Santa
Cruz Biotechnology, Buenos Aires, Argentina), and then, an anti-
goat secondary antibody conjugated to Alexa Fluor 568 (1:500;
Molecular Probes, OR, USA) was used. After immunostaining,
nuclei were stained with DAPI, as previously described [18].
For immunodetection of synaptophysin, paraffin sections were
incubated overnight at 4uC with a rabbit polyclonal anti-
synaptophysin (1:500, Abcam, MA, USA), and then, a goat
secondary antibody conjugated with Alexa Fluor 568 (1:500,
Molecular Probes, OR, USA) was used. For immunodetection of
GFAP in Mu¨ller cells, paraffin sections were incubated overnight
at 4uC with a mouse monoclonal anti-glial fibrillary acidic protein
(GFAP) antibody conjugated to Cy3 (1:1200; Sigma Chemical
Co., St. Louis, MO, USA). For immunodetection of astrocytes,
retinas were carefully detached and flat-mounted with the vitreous
side up in superfrost microscope slides (Erie Scientific Company,
New Hampshire, USA). Wholemount retinas were incubated
overnight at 4uC with a mouse monoclonal anti-GFAP antibody,
as previously stated. Specimens were mounted with antifade
medium (Vectashield, Vector Laboratories, CA, USA) and viewed
with a fluorescence microscope (BX-50, Olympus, Tokyo, Japan)
mounted with a video camera (3CCD; Sony, Tokyo, Japan)
attached to a computer running image analysis software (Optimus,
Media Cybernetics, Silver Spring, MD, USA). Comparative digital
images from different samples were grabbed using identical time
exposition, brightness, and contrast settings. The area occupied by
GFAP(+)-astrocytes was measured in a square areas corresponding
to 0.01 mm2 and expressed as percentage of the total area. Results
obtained from eight separate quadrants (four from the center and
four from the periphery) were averaged, and the mean of 4 eyes
was recorded as the representative value, as previously described
[18,20].
For vascular endothelial growth factor (VEGF) immunodetec-
tion, paraffin sections were treated with 0.3% H2O2 in PBS for
20 min (for blocking endogenous peroxidase activity) and incu-
bated overnight at 4uC with a rabbit polyclonal anti-VEGF
antibody (1:800; Calbiochem, La Jolla, CA, USA). An immuno-
histochemical detection was performed using the LSAB2 System-
HRP (Dako, California, USA), based on biotin-streptavidin-
peroxidase, and visualized using 3,39-diaminobenzidine (DAB) as
chromogen, as described [20]. For immunodetection of BDNF,
paraffin sections were incubated overnight at 4uC with a rabbit
policlonal anti-BDNF antibody (1:50; Santa Cruz Biotechnology,
Buenos Aires, Argentina), and then, an anti-rabbit secondary
antibody conjugated to Alexa Fluor 568 (1:500; Molecular Probes,
OR, USA) was used. BDNF(+) area was measured in transversal
sections (area corresponding to 0.04 mm2) and expressed as
percentage of the total area. Results obtained from four sections
were averaged, and the mean of 5 eyes was recorded as the
representative value. In all cases, some sections were treated
without the primary antibodies to confirm specificity.
Morphometric Analysis
All the images obtained were assembled and processed using
Adobe Photoshop SC (Adobe Systems, San Jose, CA) to adjust the
brightness and contrast. No other adjustments were made. For all
morphometric image processing and analysis, digitalized captured
TIFF images were transferred to ImageJ software version 1.42q
(NIH, Bethesda, MD).
Vascular Permeability
Vascular permeability was analyzed by measuring albumin-
Evan’s Blue complex leakage from retinal vessels as previously
described [20]. Briefly, animals were anesthetized, and intracar-
diacally injected with a solution of Evan’s Blue (2% w/v dissolved
in PBS). Immediately after injection, animals turned visibly blue,
confirming the dye uptake and distribution. After 40 min, animals
were killed and flat-mounted retinas were obtained as described
above. Microphotographs were obtained using identical time
exposition, brightness, and contrast settings. For each group,
results were qualitatively analyzed by comparing 5 eyes for group.
Quantification of Evan’s blue was assessed as previously described
[21]. Briefly, 40 min after Evan’s blue injection, the retina from
one eye of each animal was removed, weighted (wet weight), and
homogenized (1:5 w/v) in phosphate saline buffer (PBS). The same
volume of trichloroacetic acid (80%) was added to the homogenate
which was centrifuged for 10 min at 9000 g (4uC). The
supernatant was diluted with ethanol (1:4) and its fluorescence
was determined (excitation at 620 nm and emission at 680 nm).
Calculations were based on external standards in the same solvent
(10 to 200 ng/mL) and expressed as ng per milligram of tissue. For
each group, the mean of 5 retinas were averaged, and recorded as
the representative value.
Western blotting
Retinas (one per condition) were homogenized in 100 ml of a
buffer containing 10 mM HEPES, 1 mM EDTA, 1 mM EGTA,
10 mMKCl, Triton 0.5% (v/v), pH 7.9, supplemented with a
cocktail of protease inhibitors (Sigma Chemical Co. St. Louis,
MO, USA). After 15 min at 4uC, homogenates were gently
vortexed for 15 seconds and centrifuged at 900 g for 10 min.
Proteins (100 mg/sample) were separated in SDS, 12% polyacryl-
amide gel. After electrophoresis, proteins were transferred to
polyvinylidenedifluoride membranes for 60 min at 15 V in a Bio-
Rad Trans-Blot SD system (Bio-Rad Laboratories, Hercules, CA,
USA). Membranes were blocked in 5% non-fat dry milk in Tris-
buffered saline (pH 7.4), containing 0.1% Tween-20 for 60 min at
room temperature and then incubated overnight at 4uC with a
rabbit anti-VEGF antibody (1:1000). Membranes were washed
and then incubated for 1 h with a horseradish peroxidase-
conjugated secondary antibody (1:2000). Immunoblots were
visualized by enhanced chemiluminescence Western blotting
detection reagents (Amersham Biosciences, Buenos Aires, Argen-
tina). Autoradiographical signals were quantified by densitometry
using ImageQuant software and adjusted by the density of b-actin.
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TNFa levels assessment
Two retinas were homogenized in 150 ml of PBS, pH 7.0
supplemented with 10% fetal bovine serum heat inactivated and a
cocktail of protease inhibitors. Samples were cleared by centrifu-
gation for 10 min at 13,000 rpm. TNFa levels were determined as
previously described [22], using specific rat enzyme-linked
immunosorbent assays (ELISA) using antibodies and standards
obtained from BD Biosciences, Pharmingen, San Diego, CA,
USA, according to the manufacturer’s instructions. The reaction
was stopped and absorbance was read immediately at 450 nm on
a microplate reader (Model 3550, BIO-RAD Laboratories, CA,
USA).
Measurement of thiobarbituric acid reactive substances
(TBARS) levels
Retinas were homogenized in potassium buffer plus 60 mM
KCl, pH 7.2 and TBARS levels were analyzed as previously
described [22]. The reaction mixture contained: retinal homog-
enate, 10% SDS, and 0.8% thiobarbituric acid dissolved in 10%
acetic acid (pH 3.5), and this solution was heated to 100uC for
60 min. After cooling, the precipitate was removed by centrifu-
gation at 3200 g for 10 min. Then, 1.0 ml water and 5.0 ml of n-
butanol-pyridine mixture (15:1, vol/vol) were added, and the
mixture was vigorously shaken and centrifuged at 2000 g for
15 min. The absorbance of the organic layer was measured at an
emission wavelength of 553 nm by using an excitation wavelength
of 515 nm with a Jasco FP 770 fluorescence spectrophotometer
(Japan Spectroscopic Co. Ltd., Tokyo, Japan). The range of the
standard curves of malondialdehydebis-dimethyl acetal (MDA)
was 10–2000 pmol.
Protein level assessment
Protein content was determined by the method of Lowry et al.
[23], using BSA as the standard.
Statistical analysis
The results were analyzed by two-way ANOVA in a completely
randomized design (diabetes and EE). Comparisons were made
with the Tukey’s test. Results were considered significant at p,
0.05.
Results
The average body weight and blood glucose levels from animals
injected with vehicle or STZ are shown in Table 1. A significant
weight loss and an increase in blood glucose levels were observed
at 3, 7, and 10 weeks after STZ injection, as compared with
vehicle-injected rats. EE housing did not change these parameters
in control (data not shown) or diabetic animals. At 10 weeks of
diabetes, the occurrence of diabetic cataract was similar in SE- and
EE-housed rats (Table 1).
Figure 2 depicts the electroretinographic activity in control and
diabetic animals housed in SE or EE. In eyes from diabetic
animals housed in SE, a gradual decrease in the scotopic ERG a-
wave and b-wave amplitude was observed, which reached
significance at 5 weeks post-injection of STZ. EE housing
significantly prevented the diabetes-induced decrease in ERG a-
and b-wave amplitude (Figure 2A). The ERG a- and b-wave
latency did not differ among groups (data not shown). Represen-
tative ERG waveforms registered at 6 and 10 weeks of diabetes are
shown in Figure 2B. The sum of OP amplitudes significantly
decreased after 5 weeks of diabetes in animals housed in SE, as
compared with vehicle-injected animals, whereas EE housing
prevented the effect of diabetes on this parameter (Figure 2C and
2D). No significant differences in the ERG were observed between
eyes from vehicle-injected animals housed in SE or in EE along the
study (data not shown).
At 10 weeks after vehicle or STZ injection, retinal thickness
(Figure 3A and 3C), and the number of Brn3a(+) ganglion cell
layer (GCL) cells (Figure 3B and 3D) did not differ among groups.
EE housing of non-diabetic rats did not affect these parameters
(data not shown). In order to analyze the effect of experimental
Table 1. Average body weight, blood glucose concentration, and cataract prevalence in SE- or EE-housing animals.
Average of body weight (g) Average of blood glucose concentration (mg/dl)
Time After vehicle
or STZ injection Control Diabetes+SE Diabetes+EE Control Diabetes+SE Diabetes+EE
0 days 35266 35569 35869 11368 115611 119610
3 weeks 411614 357613a 353613a 11264 508622b 504616b
7 weeks 481617 369612b 37469b 11864 585610b 59267b
10 weeks 517611 371619b 388622b 11463 566620b 584616b
Cataract prevalence (%)
Time After vehicle or STZ injection Control Diabetes+SE Diabetes+EE
0 days 0% 0% 0%
3 weeks 0% 0% 0%
7 weeks 0% 20% 20%
10 weeks 0% 70% 70%
Body weight and blood glucose levels in vehicle- or STZ-injected animals at different time points. STZ induced a significant decrease in body weight and an increase in
blood glucose levels, which did not differ between SE- and EE-housed animals at all time points examined. Cataract occurrence was similar in both diabetic groups. Data
are mean 6 SEM (n = 10 animals per group).
a: p,0.05,
b: p,0.01 vs. aged-matched control animals, by Tukey’s test.
doi:10.1371/journal.pone.0101829.t001
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diabetes and EE on retinal synapses, synaptophysin immunoreac-
tivity was analyzed in retinas from non-diabetic and diabetic
animals housed in SE or EE. Intense immunostaining for
synaptophysin was observed in both plexiform layers from non-
diabetic animals housed in SE or EE (Figure 4A), whereas in
retinas from SE-housed animals that were diabetic for 6 weeks, a
weak immunolabeling was observed in the inner plexiform layer
(IPL). EE housing prevented the effect of experimental diabetes on
synaptophysin immunoreactivity in the IPL. Retinal immunore-
activity for GFAP and vimentin were analyzed at 6 weeks of
diabetes in animals housed in SE or EE. In SE-housed animals,
experimental diabetes induced a slight increase in retinal GFAP-
immunoreactivity associated with activated Mu¨ller cells
(Figure 4B), whereas EE housing prevented the increase in this
Figure 2. Effect of EE housing on retinal dysfunction induced by experimental diabetes. ERGs (A) and OPs (C) were weekly registered after
the induction of diabetes. Experimental diabetes induced a significant decrease in ERG a- and b-wave amplitude in eyes from animals housed in SE
(black circles), as compared with age-matched control animals (grey bar), after 5 weeks of STZ injection. In diabetic eyes from animals housed in EE
(white circles), a significant prevention of these alterations was observed. Panel B shows representative scotopic ERG traces from control and diabetic
animals housed in SE (DBT+SE) or EE (DBT+EE) assessed at 6 and 10 weeks after diabetes induction. A significant decrease in the sum of OP amplitude
(C) was observed after 5 weeks of diabetes onset in eyes from animals housed in SE, while EE housing prevented the effect of diabetes on this
parameter. Panel D shows representative OP traces from control and diabetic animals housed in SE or EE and assessed at 6 and 10 weeks after
induction of diabetes. Data are the mean 6 SEM (n= 10–12 animals per group); *p,0.05, **p,0.01 versus age-matched control; a: p,0.01 versus
diabetic animals in SE, by Tukey’s test.
doi:10.1371/journal.pone.0101829.g002
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Figure 3. Retinal histology examination after 10 weeks of diabetes. Panel A: Representative photomicrographs of retinal sections from
control eyes, and eyes from diabetic animals housed in SE (DBT+SE) or EE (DBT+EE). No evident alterations in retinal morphology were observed.
Panel B: Immunohistochemical detection of Brn3a(+) cells in the GCL from a control eye, a diabetic eye from an animal housed in SE or EE. A strong
Brn3a-immunostaining was confined to the GCL (red). Cell nuclei were counterstained with DAPI (blue). Panel C: Total retinal thickness and RGC count
evaluated by Brn3a immunostaining. These parameters did not differ among retinas from control animals housed in SE (control) and retinas from
Enriched Environment and Diabetic Retinopathy
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parameter. Vimentin-immunostaining did not change among
experimental groups (Figure 4C). In flat-mounted retinas from
non-diabetic animals, an intense GFAP-immunoreactivity was
observed in star-shaped astrocytes forming a single cell layer
adjacent to the inner limiting membrane (Figure 4D). At 6 weeks
of diabetes, GFAP-immunoreactivity in central and peripheral
retina clearly decreased in SE-housed animals, whereas in retinas
from EE-housed diabetic animals, GFAP-immunoreactivity was
similar to that observed in non-diabetic eyes, as shown in
Figure 4D. EE housing did not modify astrocyte GFAP levels in
non-diabetic animals (data not shown).
The Evan’s blue-albumin complex leakage method was used to
assess the blood retinal barrier (BRB) integrity in flat-mounted
retinas at 6 weeks after STZ injection (Figure 5). In non-diabetic
animals, the dye was exclusively localized within the vessel lumen
of the retinal vascular network, with very low to complete absence
of background fluorescence level. Large vessels showed straight
walls without leakage of the dye. In diabetic animals housed in SE,
a generalized leakiness (red background) as well as focal dye
leakage from the optic disk region and larger vessels was observed.
Moreover, constrictions and varicosities, characteristic of diabetes,
were observed in large vessels. In eyes from EE-housed diabetic
animals, there was no evidence of BRB integrity loss, and large
vessels morphology was preserved. In diabetic animals housed in
SE, retinal levels of Evan’s blue significantly increased as
compared with non-diabetic animals, whereas in diabetic animals
housed in EE, retinal Evan’s blue levels were similar to those found
in control (non-diabetic) animals, as shown in the right panel of
Figure 5. EE housing in non-diabetic animals did not change
retinal Evan’s blue levels (data not shown).
Retinal VEGF protein levels and localization were analyzed by
Western blot and immunohistochemistry, respectively (Figure 6).
In SE-housed animals that were diabetic for 6 weeks, VEGF levels
significantly increased in comparison with control retinas. EE
housing significantly prevented the effect of diabetes on VEGF,
reaching similar levels to those observed in control animals
(Figure 6A). A similar profile was observed after 10 weeks of
diabetes (Figure 5B). Immunohistochemical studies confirmed
these results (Figure 6C). In control animals, a weak VEGF-
immunoreactivity was observed in GCL and IPL. After 6 weeks of
diabetes, an intense immunolabeling was observed in GCL cells,
IPL, and some cells in the inner nuclear layer (INL). In EE-housed
diabetic animals, VEGF-immunoreactivity was similar to that
observed in non-diabetic eyes. A similar profile was found in
retinas from STZ-injected rats at 10 weeks post-injection. There
were no differences in VEGF protein levels and immunoreactivity
between vehicle-injected animals housed in SE or EE at both time
points.
TNFa levels were evaluated at 6 weeks after STZ injection. In
retinas from SE-housed animals, experimental diabetes induced a
significant increase in TNFa levels, whereas EE housing prevented
the effect of diabetes on this parameter, as shown in Figure 7.
Retinal lipid peroxidation was assessed at 6 weeks after STZ
injection. In SE, experimental diabetes induced a significant
increase in TBARS levels, which was prevented by EE housing
(Figure 7).
Retinal BDNF immunoreactivity was evaluated at 6 weeks after
STZ injection. No differences in BDNF immunoreactivity were
found between control retinas from animals housed in SE or EE
(Figure 8). In SE-housed animals, diabetes induced a significant
decrease in BDNF immunoreactivity, affecting the whole retinal
thickness, whereas in EE-housed diabetic animals, BDNF immu-
noreactivity was similar to that observed in non-diabetic animals
housed in SE or EE, as shown in Figure 8. The therapeutic effect
of environmental enrichment was analyzed by housing animals
with 7 weeks of diabetes in EE. EE provoked a significant
reversion of the diabetes-induced decrease in the ERG a- wave, b-
wave, and OP amplitude, as shown in Figure 9.
Discussion
DR is a major cause of visual loss. In this study, instead of a
pharmacological or surgical approach, we housed adult diabetic
animals in EE. Notably, environmental enrichment did not affect
the weight loss and hyperglycemia, as well as the occurrence of
cataracts induced by experimental diabetes. However, the
functional and histological measurements carried out to test the
effects of EE on early retinal damage induced by diabetes,
consistently showed clear improvements with respect to SE-housed
diabetic animal: ERG recordings confirmed preservation of retinal
function, and structural studies showed protection of inner retina
synapses, and BRB integrity.
ERG is the most frequently used noninvasive measurement for
the assessment of retinal function. Alterations in ERG responses
have been shown in both animals and humans with diabetes
[20,24,25]. EE housing which did not show any effect in control
retinas, prevented the progressive decrease in ERG a-wave, b-
wave, and OP amplitude induced by experimental diabetes.
Although it is becoming increasingly clear that retinal cells are
affected by diabetes, the retinal cell degeneration rate varies in
different experimental models, with a clear progression over the
duration of diabetes. Barber et al. [26] demonstrated that the total
number of cell bodies in the GCL is reduced by 10% after 7.5
months of diabetes. In our experimental conditions, at least at 10
weeks of experimental diabetes, no differences in retinal
morphology and RGC number between diabetic and non-diabetic
groups were observed. In this sense, one limitation to the
conclusions that can be drawn from this study relies on the fact
that the relatively short duration of diabetes (i.e. 10 weeks of
diabetes) may be not sufficient to produce irreversible retinal
changes. However, in our hands, Wistar rats with hyperglycemia in
a range of ,500 mg/dl for longer periods became considerably
sick, which can affect their differential behavior in SE and EE
cages, and therefore the beneficial effects of EE housing could be
masked.
Synaptophysin, a highly abundant integral presynaptic vesicle
membrane protein, is commonly used as a quantifiable proxy for
functional presynaptic terminals [27,28]. Despite the preservation
of RCG number, a decrease in synaptophysin immunoreactivity
was observed in the retinal IPL from diabetic animals housed in
SE at early stages of diabetes (i.e., 6 weeks after STZ injection), in
agreement with other reports [29,30]. EE housing significantly
prevented the decrease in synaptophysin immunoreactivity
induced by diabetes, supporting a preservation of synaptic
connections between inner retinal neurons.
Retinal glia has been implicated in early stages of DR (reviewed
in [31]). In agreement with the results shown herein, it has been
previously demonstrated that experimental diabetes increases
diabetic animals housed in SE or EE. Scale bar: 50 mm. Data are the mean 6 SEM (n= 5 eyes per group). GCL, ganglion cell layer; IPL, inner plexiform
layer; INL, inner nuclear layer; ONL, outer nuclear layer; OS, outer segments of photoreceptors.
doi:10.1371/journal.pone.0101829.g003
Enriched Environment and Diabetic Retinopathy
PLOS ONE | www.plosone.org 8 July 2014 | Volume 9 | Issue 7 | e101829
Figure 4. Effect of EE housing on retinal synaptophysin- and Mu¨ller cell and astrocyte GFAP-immunoreactivity. Panel A:
Representative photomicrographs of retinal sections from a vehicle injected animal housed in SE or EE, and a diabetic animal housed in SE or EE. At 6
weeks of experimental diabetes, a decrease in IPL synaptophysin levels was observed in SE-housed animals, whereas EE housing prevented the
decrease in synaptophysin immunoreactivity in the IPL from diabetic rats. No evident differences in synaptophysin levels were observed in the ONL
among groups. In non-diabetic animals, EE did not affect synaptophysin immunoreactivity. Shown are photographs representative of four eyes per
group. Panel B: In SE-housed diabetic animals, a slight increase in Mu¨ller cell process GFAP levels (arrow) was observed which was not evident in EE-
housed diabetic animals Panel C: no changes in vimentin-immunoreactivity were observed among groups. Panel D: Assessment of astrocyte GFAP-
immunoreactivity in flat-mounted retinas after 6 weeks of diabetes induction. In control retinas, astrocytes were intensely immunoreactive for GFAP
in the central and peripheral regions. The intensity of GFAP-immunoreactivity was significantly reduced in eyes from diabetic animals housed in SE,
both in the peripapillary and the peripheral regions. In eyes from diabetic animals housed in EE, a prevention of the decrease in GFAP-
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GFAP levels in Mu¨ller cells and decreases its expression in
astrocytes [32]. Mu¨ller cells participate in the establishment of the
BRB, and a disturbance of this function is assumed to contribute to
vessel leakage in the diabetic retina [31]. Mu¨ller cells that do not
express GFAP under physiological conditions are known to
express GFAP in pathological situations, including experimental
type 1 diabetes [32,33]. In SE-housed animals, experimental
diabetes provoked a moderate gliosis in Mu¨ller cells, as shown by
an increase in GFAP-immunoreactivity in these cells, which was
prevented by EE housing. Astrocytes are in close association to
vessels and capillaries, contributing to maintain their integrity, and
increasing retinal vascular endothelium barrier properties. In
agreement with previous reports [20,32], experimental diabetes
induced a decrease in astrocyte GFAP-immunoreactivity in SE-
housed rats which was not observed in EE-housed diabetic
animals.
Evan’s blue binds irreversibly to serum albumin; thus, its
distribution reflects albumin exchange between the intra- and
extravascular compartments. Evan’s blue has been widely used for
BRB integrity studies [34,35]. As previously described [20], in the
retina from SE-housed diabetic animals, extravasated Evan’s blue
was observed, whereas EE-housing protected the BRB integrity.
Since a reduction of GFAP-expression in retinal astrocytes and an
increase in Mu¨ller cell GFAP levels during diabetes were linked to
a reduced ability to maintain BRB integrity [31,32], it seems likely
that changes in GFAP-immunoreactivity in Mu¨ller cells and
astrocytes could be involved in Evan’s blue leakage in eyes from
SE-housed diabetic rats, and for the preservation of BRB integrity
induced by EE.
The present results suggest that at retinal level, EE may act
through different pathways, particularly regulating retinal VEGF,
TNFa, oxidative stress, and BDNF levels. Many lines of evidence
support that VEGF, as an angiogenesis inducer, plays a key role in
DR, and its role in the BRB breakdown is well established [36].
Intravitreal VEGF injections in monkey eyes reproduce many
features of both non proliferative and proliferative DR [37]. Anti-
VEGF therapies show promising benefits against advanced stages
of DR [38,39]. Since EE-housing prevented the increase in retinal
VEGF levels induced by diabetes, it seems likely that VEGF could
be a target for the protective effect of EE.
Both inflammation and oxidative stress play a significant role in
the pathobiology of DR [40,41]. In this sense, a significant
increase in retinal TNFa levels and lipid peroxidation was
observed in SE-housed diabetic animals, whereas EE prevented
the increase in these parameters. In agreement, it was recently
shown that EE housing attenuates the increase in hippocampal
TNFa levels in a mouse model of influenza infection [42], and
decreases lipid peroxidation after transient middle cerebral artery
occlusion in rats [43].
BDNF plays a major role in EE-mediated neuroprotection.
Landi et al. [44] have shown that an increase in BDNF expression
is necessary for EE effects on the maturation of retinal acuity. In
the adult, BDNF expression that enhances and supports brain
plasticity is increased by EE housing [45–47]. It was shown that
serum and retinal levels of BDNF are significantly reduced at early
stages of diabetes in rats [48], and BDNF protects retinal neurons
from hyperglycemia in vitro [49], supporting that decreased BDNF
levels may damage retinal cells early in the course of diabetes. In
agreement, BDNF-immunoreactivity decreased in the retina from
SE-housed diabetic animals as compared with non-diabetic
animals, whereas EE housing prevented the effect of experimental
diabetes on BDNF immunoreactivity. In retina, there are two
immunoreactivity induced by diabetes was observed both in central and peripheral regions. Right panel: Schematic diagram of a flat-mounted retina
showing all the regions analyzed. Assessment of the GFAP immunoreactivity area. Data are the mean6 SEM (n= 5 eyes per group); **p,0.01, versus
age-matched controls; a: p,0.01, versus diabetic animals housed in SE, by Tukey’s test. Scale bar: 50 mm for panel A, B and C, and scale bar: 100 mm
for panel D.
doi:10.1371/journal.pone.0101829.g004
Figure 5. Effect of EE on BRB integrity. Left panel: Visualization of retinal blood vessel leakage after intravascular perfusion with Evan’s blue. In
control retinas, the large vessels were sharply outlined without the presence of the dye outside the lumen. At 6 weeks of diabetes, in retinas from
animals housed in SE (DBT+SE), focal sites of leakage were noticed (arrow), with the dye diffusely distributed through the retinal parenchyma. Focal
varicosities (arrowhead) were also noticed. In eyes from diabetic animals housed in EE (DBT+EE), vascular permeability and large vessel morphology
were similar to control (non-diabetic) animals. Shown are microphotographs 406(upper panel A) and 4006(lower panel A), representative of 5 eyes/
group. Scale bar: 500 mm (upper panel) and 50 mm (lower panel). Right panel: Assessment of retinal Evan’s blue levels. In SE-housed animals, diabetes
induced a significant increase in this parameter, which was significantly reduced in diabetic animals housed in EE. Data are the mean 6 SEM (n = 5
eyes per group); *p,0.05, versus age-matched controls; b: p,0.05, versus diabetic animals housed in SE, by Tukey’s test.
doi:10.1371/journal.pone.0101829.g005
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Figure 6. Effect of EE housing on retinal VEGF levels. Panel A: representative Western blot performed at 6 weeks after the injection of STZ.
VEGF levels significantly increased in retinas from diabetic animals housed in SE as compared with age-matched controls. The increase in VEGF levels
induced by diabetes was totally prevented by EE housing. A similar profile was observed in animals that were diabetic for 10 weeks (Panel B).
Densitometric analysis for both time points is shown on the right. Data are the mean6 SEM (n= 5 animals per group); **p,0.01 versus age-matched
controls; a: p,0.01 versus diabetic animals housed in SE, by Tukey’s test. Panel C: Localization of VEGF in retinal sections, at 6 and 10 weeks after the
injection of vehicle or STZ. In control retinas, a weak immunoreactivity was diffusely observed throughout the inner retina and in the GCL (arrow). In
retinas from diabetic rats housed in SE, an intense immunoreactivity in the inner plexiform layer, some cells in the inner nuclear layer and perikarya in
GCL cells (arrows) was observed both 6 and 10 weeks after diabetes induction. No immunoreactivity for VEGF was observed in the outer retina. EE
housing prevented the effect of diabetes on VEGF-immunoreactivity. Shown are photographs representative of four eyes per group.
doi:10.1371/journal.pone.0101829.g006
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sources of endogenous BDNF: one source is the local production
of BDNF (mainly by Mu¨ller cells), and the other source is BDNF
retrogradely transported from the brain, that reaches RGC [50].
Since a pan-retinal increase in BDNF levels was observed in EE-
housed diabetic animals, the present results suggest that both
BDNF sources could be involved in retinal diabetic damage and in
its prevention by EE housing. In this way, BDNF produced by
Mu¨ller cells which span the entire thickness of the retina, could
reach the inner and outer nuclear layers, while BDNF retrogradely
transported from the brain could increase the neurotrophin levels
in RGC from diabetic animals housed in EE. LaVailet al. [51]
reported that photoreceptors could be significantly protected from
the damaging effects of light by intravitreal injection of BDNF.
This finding could suggest that the ERG preservation in diabetic
animals housed in EE could involve a BDNF-dependent
mechanism. In agreement, it was demonstrated that expression
of BDNF resulted in a significant delay in photoreceptor cell
death, and maintenance of retinal function assessed by ERG
recording in a model of primary rod photoreceptor degeneration
[52]. Monocular deprivation decreases BDNF levels in the
deprived eye [53], which suggests that visual experience with its
associated neuroelectric activity have an impact on BDNF
expression in the retina. Since EE is visually complex in
comparison with typical laboratory home cages, the increase in
sensorial activity of rats kept in EE could provoke a higher
production of the neurotrophin in diabetic retinas. Some possible
factors that may increase BDNF expression would be illumination,
contrast, spatial frequency and the widened area of the accessible
environment that may increase the range of depth perception [52].
Thus, although the possibility that EE might impact other systemic
effects of diabetes, such as insulin resistance, HbA1c, blood
pressure, and stress hormone expression cannot be formally ruled
out, the present results suggest that EE behaved as an anti-VEGF,
anti-inflammatory, anti-oxidative therapy, and increased BDNF in
the context of retinal damage induced by early diabetes. In
addition, EE favors stress-free and challenge-free interactions in a
stimulating surrounding that might enhance self-defense responses
of the retina to disease [16]. Moreover, considering the higher size
of EE cages, an increased physical activity could also contribute to
the beneficial effects of EE housing.
DR is a complex disease which involves many pathological
pathways; thus, therapeutic strategies with multiple modes of
actions are likely more effective in the management of the disease.
Taken together, these results indicate that a significant prevention
of early retinal changes induced by diabetes can be achieved by
EE housing. However, the fact that EE housing started before the
appearance of retinal changes provoked by experimental diabetes
could limit the relevance of these results. Therefore, in order to
analyze whether environmental enrichment could not only
prevent but also reduce DR progression, we housed diabetic
animals at 7 weeks of diabetes onset, a time point at which
functional alterations were already evident. As shown herein, a
short term exposure to EE already induced a significant protection
of the retinal function (ERG) in diabetic rats. These results indicate
that the EE not only preserved, but also restored the retinal
function, supporting that EE could be capable of suppressing
actively ongoing retinal damage. It should be noted that at 10
weeks after STZ injection, some SE- and EE-housed diabetic
animals developed cataract. However, since the incidence of
cataract was similar in SE- and EE-housed rats, it seems unlikely
that the occurrence of cataract could account for the protective
effect of EE on retinal function at 10 weeks of diabetes.
Current data remain incapable of addressing which components
of EE (motor, sensory, cognitive, or social stimulation) are
responsible for the retinal protection against early diabetic
damage, but ongoing studies by our group are in progress to
analyze this issue. Despite that more studies are required to define
the mechanism responsible for the retinal protection of adult
diabetic animals in enriched conditions, the non-invasive nature of
EE makes this tool particularly worthy of further examination.
Figure 7. Effect of EE housing on retinal TNFa and TBARS levels. In SE-housed animals, diabetes induced a significant increase in TNFa and
lipid peroxidation levels, whereas EE housing totally prevented the increase in these parameters. Data are mean 6 SEM (n= 5 animals per group),
*p,0.05 versus age-matched controls; b: p,0.05, a: p,0.01 vs. diabetic animals housed in SE, by Tukey’s test.
doi:10.1371/journal.pone.0101829.g007
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Figure 8. Expression of BDNF in retinas after 6 weeks of diabetes onset in SE- or EE-housed animals. In animals housed in SE a decrease
in BDNF immunostaining in both inner and outer retina was observed, whereas in retinas from diabetic animals housed in EE, BDNF expression was
similar to control animals kept in SE or EE. Shown are photographs representative of four eyes per group. Right panel: Assessment of the BDNF(+)
immunoreactivity area. In SE-housed animals, experimental diabetes induced a decrease in BDNF(+) area which was prevented in diabetic animals
housed in EE. Data are the mean 6 SEM (n= 5 eyes per group); **p,0.01, versus age-matched controls; a: p,0.01, versus diabetic animals housed in
SE, by Tukey’s test. Scale bar: 50 mm. GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; ONL, outer nuclear layer; OS, outer
segments of photoreceptors.
doi:10.1371/journal.pone.0101829.g008
Figure 9. Effect of EE housing started at 7 weeks after diabetes onset on retinal function. In diabetic animals kept in SE (black circles), a
significant decrease in scotopic ERG a- and b-wave amplitude which progressed over time until 10 weeks as compared with non-diabetic animals
(grey bar) was observed, whereas a significant protection of retinal function was already evident after 1 week of EE housing (white circles). For OP
amplitude, EE housing reversed the decrease induced by STZ at 2 weeks after EE exposure, and the protection induced by EE housing persisted until
week 10. Data are the mean 6 SEM (n= 10–12 animals per group); *p,0.05, **p,0.01 versus non diabetic eyes; a: p,0.01, b: p,0.05 versus diabetic
eyes housed in SE, by Tukey’s test. Panel B shows representative scotopic ERG and OP traces.
doi:10.1371/journal.pone.0101829.g009
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